Sanara MedTech Inc. (SMTI) Financial Statements (2025 and earlier)

Company Profile

Business Address 1200 SUMMIT AVE
FORT WORTH, TX 76102
State of Incorp. TX
Fiscal Year End December 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,1478,95918,6534556,612732
Cash and cash equivalents5,1478,95918,6534556,612732
Receivables 6,904160   
Inventory, net of allowances, customer advances and progress billings4,7183,5492,0481,148747 
Inventory4,7183,5492,0481,148747 
Other undisclosed current assets9,1411,2043,7482,8791,497247
Total current assets:19,00620,61724,6084,4828,856978
Noncurrent Assets
Operating lease, right-of-use asset1,995806413468 
Property, plant and equipment1,2581,4161,63067920553
Long-term investments and receivables3,0843,0845,0171,100  
Long-term investments3,0843,0845,0171,100  
Intangible assets, net (including goodwill)48,52835,1124,7283,0981,47152
Goodwill3,6023,602    
Intangible assets, net (excluding goodwill)44,92631,5104,7283,0981,47152
Other undisclosed noncurrent assets     5851,958
Total noncurrent assets:54,86540,41911,7885,3442,2612,064
TOTAL ASSETS:73,87161,03536,3969,82611,1173,042
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,72411,2955,6633,1912,454330
Accounts payable  1,39343827133854
Accrued liabilities9,7249,9035,2252,9192,116276
Debt 580     
Deferred rent credit      10
Other liabilities1,1001,163    
Due to related parties341562246963
Other undisclosed current liabilities2,363314203126118 
Total current liabilities:13,76812,8066,0223,5402,640404
Noncurrent Liabilities
Long-term debt and lease obligation9,113 222356  
Long-term debt, excluding current maturities9,113     
Liabilities, other than long-term debt4,4606,509 90  
Other liabilities2,7236,004 90  
Operating lease, liability1,737505222356 
Other undisclosed noncurrent liabilities1,942 (222) 2,0851,526
Total noncurrent liabilities:15,5156,5092224462,0851,526
Total liabilities:29,28319,3156,2443,9864,7251,930
Equity
Equity, attributable to parent44,83241,82830,6406,1516,6141,112
Preferred stock     11,368 
Common stock98864237
Treasury stock, value      (12)
Additional paid in capital72,86165,21445,86813,177(2,082)48,356
Accumulated deficit(28,037)(23,395)(15,235)(7,032)(2,676)(47,469)
Equity, attributable to noncontrolling interest(244)(108)(488)(310)(222) 
Total equity:44,58841,72030,1525,8406,3921,112
TOTAL LIABILITIES AND EQUITY:73,87161,03536,3969,82611,1173,042

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues64,99045,84324,14415,587 5,838
Cost of revenue(7,853)(6,361)(2,311)(1,617) (507)
Cost of goods and services sold(407)(540)(252)(318)  
Gross profit:57,13739,48221,83313,970 5,330
Operating expenses(61,352)(51,714)(29,209)(19,005) (5,832)
Operating loss:(4,215)(12,232)(7,376)(5,035) (502)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(225)(1,705)(618)589 (99)
Interest and debt expense(476)(285)(1)586 (87)
Loss from continuing operations before equity method investments, income taxes:(4,916)(14,222)(7,995)(3,859) (687)
Other undisclosed income from continuing operations before income taxes476285    
Loss from continuing operations before income taxes:(4,440)(13,937)(7,995)(3,859) (687)
Income tax benefit  5,845    
Loss from continuing operations:(4,440)(8,092)(7,995)(3,859) (687)
Loss before gain (loss) on sale of properties:(7,995)(3,859) (687)
Net loss:(4,440)(8,092)(7,995)(3,859) (687)
Net income attributable to noncontrolling interest1371557289  
Other undisclosed net income (loss) attributable to parent   (71)(586) 87
Net loss attributable to parent:(4,303)(7,937)(7,994)(4,356) (601)
Other undisclosed net income (loss) available to common stockholders, basic   72  (131)
Net loss available to common stockholders, diluted:(4,303)(7,937)(7,922)(4,356) (732)

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(4,440)(8,092)(7,995)(3,859) (687)
Comprehensive loss:(4,440)(8,092)(7,995)(3,859) (687)
Comprehensive income, net of tax, attributable to noncontrolling interest1371557289  
Comprehensive loss, net of tax, attributable to parent:(4,303)(7,937)(7,923)(3,770) (687)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: